We are 3,3,4,4,5,5,6,6,6-nonafluorohexan-1-ol CAS:2043-47-2 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
Molecular Formula: C6H5F9O
Density: 1.59 g/mL at 25 °C(lit.)
Boiling point: 140-143 °C(lit.)
Flash point: 164 °F
Refractive index: n20/D 1.314(lit.)
Vapor pressure: 12.9mmHg at 25°C
Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.
Market News:Given ICER’s uncertainty regarding efgartigimod’s dosing and long-term benefits, the group said it’s moderately certain the drug can produce a “comparable, small or substantial net health benefit” in that same group of MG patients. (Z)-4-methyl-3,5-hexadien-2-ol manufacturer.A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc. Benzo[2,1-b:3,4-b’]dithiophene, 8a,8b-dihydro- supplier.The European Medicines Agency on Friday rejected Kyowa Kirin’s Parkinson’s disease drug Nouryant (istradefylline), which the US FDA approved in 2019 under the brand name Nourianz. diethyl (R)-(1-(3,5-dinitrobenzamido)-2-hydroxyethyl)phosphonate producer.